author-photo

A Gratwohl

Heidelberg University

153

Papers

5719

Citations

Citation Trend

Filter By

Papers (115) Sort By

Journal Conference Others

Erratum: Latin America: the next region for haematopoietic transplant progress

2017 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (3)
Assessment of IMATINIB 400mg as first line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV

2017 Haematologica
Show All
- Source
- Cite
- Save
Citations (2)
The EBMT–ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis

2017 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (10)
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

2017 Leukemia
Show All
- Source
- Cite
- Save
Citations (146)
Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

2016 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (195)
Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT

2015 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (58)
Erratum: Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice (Bone Marrow Transplantatio (2014) 49 (319) DOI:10.1038/bmt.2013.210)

2014 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (6)
Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program.

2012 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (17)
Improved survival by allogeneic haematopoietic stem cell transplantation versus autologous HSCT or chemotherapy as consolidation therapy in AML CR1 patients aged 40-60 years

2012 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation

2012 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (63)